Vertex Pharmaceuticals (VRTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX)

VRTX 434.76

+0.1%

Nov 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (408)	5/11/2000 1:16:00 AM
From: tommysdad	Read Replies (2) of 1169

Wow. One of the most visionary alliances in recent biotech history and no reaction from this board. This is low-risk from the Novartis side. High payouts will only come if Vertex delivers important molecules that address real markets. If Vertex wants to hand off a molecule Novartis doesn't want, they just say no. Apparently, Novartis resources only come in to play when compounds are ready for advanced clinicals. This is low-risk from the Vertex side. Big Brother is paying the bills, and they (maybe/probably) get co-promotion rights on home runs and get to keep the solid base hits. More astonishing is that Vertex runs the show all the way into early clinicals. This isn't simply a large company liking a biotech's technology, this is Novartis trusting Vertex to make the right decisions throughout the drug discovery process. Who has heard of such a thing? It sounds too good to be true. Is it?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next